Ferritin level is associated with metabolic syndrome and elevated alanine aminotransferase in children and adolescents

References

1. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2010;375:181–3.10.1016/S0140-6736(09)61794-3Suche in Google Scholar

2. Choi KM, Kim SM, Kim YE, Choi DS, Baik SH, et al. International Diabetes Federation. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism 2007;56:552–8.10.1016/j.metabol.2006.12.003Suche in Google Scholar PubMed

3. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403–14.10.1016/j.jacc.2006.09.032Suche in Google Scholar PubMed

4. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1–10.10.7326/0003-4819-137-1-200207020-00006Suche in Google Scholar PubMed

5. Park HK, Hwang JS, Moon JS, Lee JA, Kim DH, et al. Healthy range of serum alanine aminotransferase and its predictive power for cardiovascular risk in children and adolescents. J Pediatr Gastroenterol Nutr 2013;56:686–91.10.1097/MPG.0b013e31828b4e67Suche in Google Scholar PubMed

6. Marchesini G, Bugianesi E, Forlani G, Marzocchi R, Zannoni C, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917–23.10.1053/jhep.2003.50161Suche in Google Scholar PubMed

7. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341–50.10.1056/NEJMra0912063Suche in Google Scholar PubMed

8. Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta 2010;1800:760–9.10.1016/j.bbagen.2010.03.011Suche in Google Scholar PubMed PubMed Central

9. Abril-Ulloa V, Flores-Mateo G, Solà-Alberich R, Manuel-y-Keenoy B, Arija V. Ferritin levels and risk of metabolic syndrome: meta-analysis of observational studies. BMC Public Health 2014;14:483.10.1186/1471-2458-14-483Suche in Google Scholar PubMed PubMed Central

10. Kunutsor SK, Apekey TA, Walley J, Kain K. Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence. Diabetes Metab Res Rev 2013;29:308–18.10.1002/dmrr.2394Suche in Google Scholar PubMed

11. Zhao Z, Li S, Liu G, Yan F, Ma X, et al. Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis. PLoS One 2012;7:e41641.10.1371/journal.pone.0041641Suche in Google Scholar PubMed PubMed Central

12. Kim CW, Chang Y, Sung E, Shin H, Ryu S. Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men. Metabolism 2012;61:1182–8.10.1016/j.metabol.2012.01.007Suche in Google Scholar PubMed

13. Trombini P, Piperno A. Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons. J Hepatol 2007;46:549–52.10.1016/j.jhep.2007.01.004Suche in Google Scholar PubMed

14. Sun L, Franco OH, Hu FB, Cai L, Yu Z, et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocr Metab 2008;93:4690–6.10.1210/jc.2008-1159Suche in Google Scholar PubMed

15. Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, et al. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr 2008;51:1–25.10.3345/kjp.2008.51.1.1Suche in Google Scholar

16. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003;157:821–7.10.1001/archpedi.157.8.821Suche in Google Scholar PubMed

17. Yi KH, Hwang JS, Kim EY, Lee SH, Kim DH, et al. Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: a population-based study. Diabetes Res Clin Pract 2014;103:106–13.10.1016/j.diabres.2013.10.021Suche in Google Scholar PubMed

18. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004;27:2422–8.10.2337/diacare.27.10.2422Suche in Google Scholar PubMed

19. Kang HT, Linton JA, Shim JY. Serum ferritin level is associated with the prevalence of metabolic syndrome in Korean adults: the 2007–2008 Korean National Health and Nutrition Examination Survey. Clin Chim Acta 2012;413:636–41.10.1016/j.cca.2011.12.011Suche in Google Scholar PubMed

20. Vari IS, Balkau B, Kettaneh A, André P, Tichet J, et al. DESIR Study Group. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007;30:1795–801.10.2337/dc06-2312Suche in Google Scholar PubMed

21. Park SK, Ryoo JH, Kim MG, Shin JY. Association of serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study. Diabetes Care 2012;35:2521–6.10.2337/dc12-0543Suche in Google Scholar

22. Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2012;55:77–85.10.1002/hep.24706Suche in Google Scholar

23. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels. J Hepatol 2007;46:700–7.10.1016/j.jhep.2006.09.018Suche in Google Scholar

24. Brudevold R, Hole T, Hammerstrøm J. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload. PLoS One 2008;3:e3547.10.1371/journal.pone.0003547Suche in Google Scholar

25. Fabbrini E, Magkos F, Mohammed BS, Pietka T. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009;106:15430–5.10.1073/pnas.0904944106Suche in Google Scholar

26. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 2007;56:792–8.10.1016/j.metabol.2007.01.010Suche in Google Scholar

27. Yun KE, Shin CY, Yoon YS, Park HS. Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. Atherosclerosis 2009;205:533–7.10.1016/j.atherosclerosis.2008.12.012Suche in Google Scholar

28. Stefan N, Häring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol 2013;9:144–52.10.1038/nrendo.2012.258Suche in Google Scholar

29. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010;52:1156–61.10.1002/hep.23789Suche in Google Scholar

30. Ferrannini E. Insulin resistance, iron, and the liver. Lancet 2000;355:2181–2.10.1016/S0140-6736(00)02397-7Suche in Google Scholar

31. González AS, Guerrero DB, Soto MB, Díaz SP, Martinez-Olmos M, et al. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr 2006;60:802–9.10.1038/sj.ejcn.1602384Suche in Google Scholar PubMed

32. Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology 2009;49:887–900.10.1002/hep.22716Suche in Google Scholar PubMed PubMed Central

33. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005;7:1040–52.10.1089/ars.2005.7.1040Suche in Google Scholar PubMed

34. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 2010;7:251–64.10.1038/nrgastro.2010.41Suche in Google Scholar PubMed

35. Christides T, Sharp P. Sugars increase non-heme iron bioavailability in human epithelial intestinal and liver cells. PLoS One 2013;8:e83031.10.1371/journal.pone.0083031Suche in Google Scholar PubMed PubMed Central

36. Stitt C, Charley PJ, Butt EM, Saltman P. Rapid induction of iron deposition in spleen and liver with an iron-fructose chelate. Proc Soc Exp Biol Med 1962;110:70–1.10.3181/00379727-110-27426Suche in Google Scholar PubMed

37. Abid A, Taha O, Nseir W, Farah R, Grosovski M, et al. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009;51:918–24.10.1016/j.jhep.2009.05.033Suche in Google Scholar PubMed

38. Tsuchiya H, Ebata Y, Sakabe T, Hama S, Kogure K, et al. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism 2013;62:62–9.10.1016/j.metabol.2012.06.008Suche in Google Scholar PubMed

39. Hämäläinen P, Saltevo J, Kautiainen H, Mäntyselkä P, Vanhala M. Serum ferritin levels and the development of metabolic syndrome and its components: a 6.5-year follow-up study. Diabetol Metab Syndr 2014;6:114.10.1186/1758-5996-6-114Suche in Google Scholar PubMed PubMed Central

40. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007;50:949–56.10.1007/s00125-007-0604-5Suche in Google Scholar PubMed

41. Licata A, Nebbia ME, Cabibbo G, Iacono GL, Barbaria F, et al. Hyperferritinemia is a risk factor for steatosis in chronic liver disease. World J Gastroenterol 2009;15:2132–8.10.3748/wjg.15.2132Suche in Google Scholar

42. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54.10.1056/NEJM199902113400607Suche in Google Scholar

43. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes 2001;50:2444–50.10.2337/diabetes.50.11.2444Suche in Google Scholar

44. Hannan TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res 2006;60:759–63.10.1203/01.pdr.0000246097.73031.27Suche in Google Scholar

45. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388–93.10.1542/peds.2006-1212Suche in Google Scholar

46. Castiella A, Zapata E, Zubiaurre L, Ma Alustiza J, De Juan MD, et al. Impact of H63D mutations, magnetic resonance and metabolic syndrome among outpatient referrals for elevated serum ferritin in the Basque Country. Ann Hepatol 2015;14:333–9.10.1016/S1665-2681(19)31272-4Suche in Google Scholar